1YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
4-Bromo-2-nitrobenzyl alcohol | 4-溴-2-硝基苄醇 | 22996-19-6 |
1,3-DIOXO-2-ISOINDOLINEETHANESULFONIC ACID, POTASSIUM SALT | 1,3-DIOXO-2-ISOINDOLINEETHANESULFONIC ACID, POTASSIUM SALT | 91893-72-0 |
Taladegib | 4-氟-N-甲基-N-[1-[4-(1-甲基-1H-吡唑-5-基)-1-酞嗪基]-4-哌啶基]-2-(三氟甲基)苯甲酰胺 | 1258861-20-9 |
MK-0752 | 顺式-4-[(4-氯苯基)磺酰基]-4-(2,5-二氟苯基)环己烷丙酸 | 471905-41-6 |
LY2157299 (Galunisertib) | LY 2157299 | 700874-72-2 |
N-Boc-4-Methylene-L-proline Methyl Ester | N-BOC-4-亚甲基-L-脯氨酸甲酯 | 84348-39-0 |
Vistusertib (AZD-2014) | 3-[2,4-双((3S)-3-甲基吗啉-4-基)吡啶并[5,6-E]嘧啶-7-基]-N-甲基苯甲酰胺 | 1009298-59-2 |
Afuresertib hydrochloride | N-((S)-1-氨基-3-(3-氟苯基)丙-2-基)-5-氯-4-(4-氯-1-甲基-1H-吡唑-5-基)噻吩-2-甲酰胺盐酸盐 | 1047645-82-8 |
Tirabrutinib | 替拉鲁替尼 | 1351636-18-4 |
EPZ015666 | EPZ015666 | 1616391-65-1 |
1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 864686-28-2 | 864686-28-2 |
Sitravatinib | CS-2638 | 1123837-84-2 |
BAY1143572 | ATUVECICLIB RACEMATE (BAY-1143572 RACEMATE) | 1414943-88-6 |
Futibatinib | FGFR抑制剂(FGFR-IN-1) | 1448169-71-8 |
METHYL BIPHENYL-2-CARBOXYLATE | 2-羧酸联苯甲酯 | 16605-99-5 |
Carbamic acid, N-[4-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)butyl]-, 1,1-dimethylethyl ester | 叔丁基(4-(1,3-二氧异喹啉-2-基)氨基甲酸酯 | 188957-09-7 |
Fedratinib (TG101348) | N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-[2-(1-吡咯烷基)乙氧基]苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 | 936091-26-8 |
Volasertib | N-[反式-4-[4-(环丙基甲基)-1-哌嗪基]环己基]-4-[[(7R)-7-乙基-5,6,7,8-四氢-5-甲基-8-异丙基-6-氧代-2-蝶啶基]氨基]-3-甲氧基苯甲酰胺 | 755038-65-4 |
RO4929097 | N1-[(7S)-6,7-二氢-6-氧代-5H-二苯并[B,D]氮杂卓-7-基]-2,2-二甲基-N3-(2,2,3,3,3-五氟丙基)丙二酰胺 | 847925-91-1 |
Zoligratinib | DEBIO-1347 | 1265229-25-1 |
EPZ020411 | EPZ020411 盐酸盐的形式 | 1700663-41-7 |
FIIN-2 | FIIN-2 | 1633044-56-0 |
Mavelertinib | PF-06747775 | 1776112-90-3 |
1-(2-(3-formyl-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 1-(2-(3-甲酰基-N-甲基苯甲酰氨基)乙基)哌啶-4-基[1,1'-联苯]-2-基氨基甲酸酯 | 864760-28-1 |
QUINOLINE-4-CARBOXYLIC ACID HYDRAZIDE | 异喹啉-4-硫代羧酸酰胺 | 435271-32-2 |
Carbamic acid, N-[1,1'-biphenyl]-2-yl-, 1-[2-[[4-(hydroxymethyl)benzoyl]methylamino]ethyl]-4-piperidinyl ester | 雷芬那新杂质1 | 1682660-39-4 |
pyridin-2-amine 1-oxide monohydrochloride | 吡啶-2-胺 1-氧化物单盐酸盐 | 57097-28-6 |
D-Phenylalanine, 3-bromo-N-[(1,1-dimethylethoxy)carbonyl]-, methyl ester | (R)-3-(3-溴苯基)-2-(叔丁氧羰基)氨基)丙酸甲酯 | 2244592-10-5 |
(2-[(TERT-BUTOXYCARBONYL)AMINO]PYRIDIN-3-YL)BORONIC ACID | 2-(叔丁氧羰基氨基)吡啶-3-硼酸 | 863753-35-9 |
Dacomitinib | 达克替尼 | 1110813-31-4 |
BAY 87-2243 | BAY87-2243 | 1227158-85-1 |
CPI-169 | 化合物CPI169 | 1450655-76-1 |
Carbamic acid, 1H-indol-2-yl-, 1,1-dimethylethyl ester (9CI) | (1H-吲哚-2-基)氨基甲酸叔丁酯 | 167954-49-6 |
N-(2-CYANOETHYL)-PHTHALIMIDE | N-(2-氰基乙基)邻苯二甲酰亚胺 | 3589-45-5 |
1-Piperidinecarboxylic acid, 4-[[([1,1'-biphenyl]-2-ylamino)carbonyl]oxy]-, 1,1-dimethylethyl ester | 4-([1,1'-联苯]-2-基氨基甲酰基)氧基)哌啶-1-甲酸叔丁酯 | 2098067-87-7 |
2,4,6-TRIMETHYLANISOLE | 2,4,6-三甲基苯甲醚 | 4028-66-4 |
GDC-0980 (Apitolisib) | (S)-1-[4-[[2-(2-氨基嘧啶-5-基)-7-甲基-4-(吗啉-4-基)噻吩并[3,2-D]嘧啶-6-基]甲基]哌嗪-1-基]-2-羟基丙-1-酮 | 1032754-93-0 |
TAK-580 (MLN2480) | MLN2480 | 1096708-71-2 |
N-(4-Aminobutyl)-phthalimide HCl | 2-(4-氨基丁基)-2,3-二氢-1H-异吲哚-1,3-二酮盐酸盐 | 35517-18-1 |
piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 哌啶-4-基 [1,1-联苯]-2-氨基甲酸酯 | 171722-92-2 |
CCT251545 | CCT251545 | 1661839-45-7 |
GSK591 | GSK591 (EPZ-015866) | 1616391-87-7 |
TAK-243 (MLN7243) | TAK-243 | 1450833-55-2 |
(2S,5R)-2,5-DIMETHYL-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER | (2S,5R)-1-N-BOC-2,5-二甲基哌嗪 | 548762-66-9 |
5,5-dimethyl-2-phenyl-morpholine | 5,5-二甲基-2-苯基吗啉 | 42013-48-9 |
GDC-0941 (Pictilisib) | GDC-0941 | 957054-30-7 |
ABC294640 | 奥帕尼布 | 915385-81-8 |
Nirogacestat | PF-3084014 | 1290543-63-3 |
Pinometostat | (2R,3R,4S,5R)-2-(6-氨基-9H-嘌呤-9-基)-5-((((1R,3S)-3-(2-(6-(叔丁基)-1H-苯并[D]咪唑-2-基)乙基)环丁基)(异丙基)氨基)甲基)四氢呋喃-3,4-二醇 | 1380288-87-8 |
CPI-203 | CPI-203 | 1446144-04-2 |
CCT-251921 | CCT251921 | 1607837-31-9 |
CFI-400945 fumarate | 1616420-30-4 | 1616420-30-4 |
N-(CINNAMOYL)-3-METHOXYANILINE | N-(肉桂酰)-3-甲氧基苯胺 | 127033-74-3 |
benzyl-(2-chloroethyl)-methyl-azanium chloride | N-(2-氯乙基)-N-甲基苄胺盐酸盐 | 23510-18-1 |
Vismodegib | 维莫德吉 | 879085-55-9 |
Sonidegib | 索尼吉布 | 956697-53-3 |
CUDC-427 | 1446182-94-0 | 1446182-94-0 |
BGT226 | BGT226 | 915020-55-2 |
(2S,3R,4S,5S)-5-(chloromethyl)tetrahydrofuran-2,3,4-triyl triacetate | (2S,3R,4S,5S)-2,3,4-三乙酰基-5-氯甲基四氢呋喃 | 185453-73-0 |
Fisogatinib | BLU554 | 1707289-21-1 |
3-Bromo-N-Boc-DL-phenylalanine methyl ester | 3-(3-溴苯基)-2-(叔丁氧羰基)氨基)丙酸甲酯 | 1822475-70-6 |
4'-Aminobiphenyl-4-carbonitrile | 4'-氨基-4-氰基联苯 | 4854-84-6 |
4-[[5-Fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]-2-pyrimidinyl]amino]phenyl][(3S)-3-(methylamino)-1-pyrrolidinyl]Methanone | [4-[[5-氟-4-[2-甲基-1-(1-甲基乙基)-1H-咪唑-5-基]-2-嘧啶基]氨基]苯基][(3S)-3-(甲氨基)-1-吡咯烷]甲酮 | 924641-59-8 |
MK-8033 | MK-8033 | 1001917-37-8 |
CHEMBRDG-BB 4012656 | (2,2,6,6-四甲基-哌啶-4-基)-甲胺 | 62995-79-3 |
LCL-161 | LCL161 | 1005342-46-0 |
Taselisib | GDC 0032 | 1282512-48-4 |
GSK2656157 | GSK2656157 | 1337532-29-2 |
BGB-102 | 17-溴-1,8,9,10,11,12,13,14-八氢-20-甲氧基-13-甲基-4,6-乙烯桥嘧啶并[4,5-B][6,1,12]苯并氧杂二氮杂环十五碳七烯 | 807640-87-5 |
AZD3965 | AZD3965 | 1448671-31-5 |
1-benzylpiperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 1-benzylpiperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 171723-80-1 |
AMG-337 | AMG-337 | 1173699-31-4 |
1,3-bis(2-phenylphenyl)urea | 雷芬那辛杂质10 | 115293-14-6 |
METHYL 5-CYANO-2-METHOXYBENZOATE | 5-氰基-2-甲氧基苯甲酸甲酯 | 40757-12-8 |
2-(3-Methoxypyridin-4-yl)ethanaMine | 3-甲氧基-4-乙氨基吡啶 | 1060801-82-2 |
Pilaralisib (XL-147) | 2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺 | 934526-89-3 |
CB-5083 | CB5083 | 1542705-92-9 |
A-1210477 | A-1210477 | 1668553-26-1 |
1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | 1-(2-(甲基氨基)乙基)哌啶-4-基[1,1'-联苯基]-2-基氨基甲酸酯 | 743460-48-2 |
PI3K-IN-32 | PIK抑制剂 | 371934-59-7 |
BAY1125976 | CS-2913 | 1402608-02-9 |
piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate Hydrochloride | 哌啶-4-基 [1,1'-联苯]-2-基氨基甲酸酯盐酸盐 | 1205552-76-6 |
TERT-BUTYL 3-AMINOBENZOATE | 3-氨基苯甲酸叔丁酯 | 92146-82-2 |
3,5-Dimethyl-4-hydroxybenzenemethanol | 4-(羟甲基)-2,6-二甲酚 | 4397-14-2 |
Adavosertib | MK-1775 | 955365-80-7 |
2-b]pyridine | 3-溴呋喃[3,2-B]吡啶 | 92404-63-2 |
6-AMINO-2,4-DIMETHYL-3-PYRIDINECARBONITRILE | 6-氨基-2,4-二甲基-3-吡啶腈 | 769-27-7 |
Ribociclib hydrochloride | 7-环戊基-N,N-二甲基-2-[[5-(1-哌嗪基)-2-吡啶基]氨基]-7H-吡咯并[2,3-D]嘧啶-6-甲酰胺盐酸盐 | 1211443-80-9 |
Avutometinib | RO5126766(CH5126766) | 946128-88-7 |
5-cyano-2-methoxybenzoic acid | 5-cyano-2-methoxybenzoic acid | 84923-71-7 |
DIAZOXIDE | 氯甲苯噻嗪 | 364-98-7 |
Morpholine, 2,6-diMethyl-, (2S,6S)- | 2S,6S-二甲基吗啉 | 276252-73-4 |
EPZ004777 | EPZ004777 | 1338466-77-5 |
4-Methyl-1,2,3,6-tetrahydropyridine hydrochloride | 4-甲基-1,2,3,6-四氢吡啶盐酸盐 | 95019-16-2 |
Acalisib | GS-9820 | 870281-34-8 |
Ceralasertib | AZD6738 | 1352226-88-0 |
Brilanestrant | (E)-3-(4-((E)-2-(2-CHLORO-4-FLUOROPHENYL)-1-(1H-INDAZOL-5-YL)BUT-1-EN-1-YL)PHENYL)ACRYLIC ACID | 1365888-06-7 |
(S)-methyl 3-(3-bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoate | (S)-methyl 3-(3-bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoate | 546115-43-9 |
5,7-dichloro-3,4-dihydro-2,6(1H)-Isoquinolinedicarboxylic acid, 2-(1,1-dimethylethyl) 6-methyl ester | 2-N-BOC-5,7-二氯-3,4-二氢-异喹啉-6-甲酸甲酯 | 851784-80-0 |
1-PHENYL-PIPERIDIN-2-ONE | N-苯基-2-哌啶酮 | 4789-09-7 |
联系方式